Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.45 |
| ▸ | CA1 | P00915 | 1/20 | 0.45 |
| ▸ | CA2 | P00918 | 1/20 | 0.45 |
| ▸ | CA9 | Q16790 | 1/20 | 0.45 |
| ▸ | QPCT | Q16769 | 2/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.44 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.44 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.44 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.44 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.44 |
| ▸ | QPCTL | Q9NXS2 | 1/20 | 0.44 |
| ▸ | IDO1 | P14902 | 3/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.40 |
| ▸ | NOS1 | P29475 | 1/20 | 0.40 |
| ▸ | NOS2 | P35228 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19468030 | 0.91 | CYP11B1 (0.49) | CYP19A1CYP11B1CYP11B2 | |
| SCHEMBL19494534 | 0.89 | CYP11B1 (0.42) | CYP1A2CYP3A4CYP2D6CYP19A1CYP11B1 | |
| SCHEMBL19468350 | 0.86 | CYP1A2 (0.42) | QPCTCYP1A2POLBCYP3A4CYP2D6 | |
| SCHEMBL19468243 | 0.85 | CYP19A1 (0.46) | QPCTCYP1A2POLBCYP3A4CYP2D6 | |
| SCHEMBL19494201 | 0.84 | TBXAS1 (0.48) | POLBCYP19A1TBXAS1 | |
| SCHEMBL19494371 | 0.84 | TBXAS1 (0.49) | CA2QPCTPOLBTBXAS1FAAH | |
| SCHEMBL19468217 | 0.83 | CYP11B1 (0.51) | CYP1A2CYP3A4CYP2D6MAPTCYP11B1 | |
| SCHEMBL19468120 | 0.83 | CYP19A1 (0.51) | CYP1A2POLBCYP19A1CYP11B1CYP11B2 | |
| SCHEMBL19468136 | 0.82 | NOS1 (0.44) | QPCTCYP1A2POLBCYP3A4CYP2D6 | |
| SCHEMBL19468174 | 0.81 | NOS1 (0.40) | QPCTCYP1A2POLBCYP3A4CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11992901-B1 | Lead-free and halogen-free solder paste | DONGGUAN CITY THOUSAND ISLAND METAL FOIL CO., LTD. (CN) | 2024-05-28 | — | — | US | claimed |
| CN-116174997-B | Lead-free halogen-free soldering paste and preparation process thereof | 东莞市千岛金属锡品有限公司 | 2023-08-25 | — | — | CN | claimed |
| CN-116174997-A | Lead-free halogen-free soldering paste and preparation process thereof | 东莞市千岛金属锡品有限公司 | 2023-05-30 | — | — | CN | claimed |
| EP-1776399-B1 | MONODISPERSE POLYMERS CONTAINING (ALKYL)ACRYLIC ACID MOIETIES, PRECURSORS AND METHODS FOR MAKING THEM AND THEIR APPLICATIONS | UNIV GENT (BE) | 2012-11-14 | — | — | EP | claimed |
| EP-4747339-A1 | INDUSTRIAL GEAR LUBRICANT | The Lubrizol Corporation (US) | 2026-05-27 | — | — | EP | disclosed |
| US-12624196-B2 | Rubber composition, vulcanized object obtained from said rubber composition, and vulcanized molded object obtained from said rubber composition | DENKA COMPANY LIMITED (JP) | 2026-05-12 | — | — | US | disclosed |
| US-12492279-B2 | Chloroprene-based block copolymer, latex, latex composition, and rubber composition | DENKA COMPANY LIMITED (JP) | 2025-12-09 | — | — | US | disclosed |
| US-20250326940-A1 | HYDROPHILIC COATINGS FOR VASCULAR MEDICAL PRODUCTS | BIOTRONIK AG (CH) | 2025-10-23 | — | — | US | disclosed |
| EP-2292668-B2 | Process for preparing polymers and compositions thereof | LUBRIZOL CORP (US) | 2025-09-10 | — | — | EP | disclosed |
| US-20250269096-A1 | FLUOROPOLYMER MEDICAL DEVICES | UNOMEDICAL AS (DK) | 2025-08-28 | — | — | US | disclosed |
| EP-4282889-B1 | (METH)ACRYLIC BLOCK COPOLYMER, (METH)ACRYLIC BLOCK COPOLYMER LATEX, (METH)ACRYLIC BLOCK COPOLYMER LATEX COMPOSITION, AND SHAPED OBJECT | DENKA COMPANY LTD (JP) | 2025-08-20 | — | — | EP | disclosed |
| EP-4583934-A1 | MEDICAL DEVICES | Unomedical A/S (DK) | 2025-07-16 | — | — | EP | disclosed |
| WO-2005031461-A1 | LOW-POLYDISPERSITY PHOTOIMAGEABLE ACRYLIC POLYMERS, PHOTORESISTS AND PROCESSES FOR MICROLITHOGRAPHY | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-04-07 | — | — | WO | disclosed |
| US-20040110964-A1 | Dithiocarbamic esters | ARLANXEO DEUTSCHLAND GMBH (DE) | 2004-06-10 | — | — | US | disclosed |
| US-6747111-B2 | POLYMERS HAVING LOW POLLYDISPERSITY AND PREDICTABLE SPECIFIC POLYMER ARCHITECTURE AND MOLECULAR WEIGHT ARE PRODUCED BY THE PROCESS. THE POLYMERS PRODUCED BY THE PROCESS ARE SUITABLE FOR USE AS BINDERS IN AUTOMOTIVE OEM AND REFINISH COATINGS. | E. I. DU PONT DE NEMOURS AND COMPANY | 2004-06-08 | — | — | US | disclosed |
| CN-1495161-A | Dithiocarbamate | — | 2004-05-12 | — | — | CN | disclosed |
| US-20040024132-A1 | Polymerization process with living characteristics and polymers made therefrom | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 2004-02-05 | — | — | US | disclosed |
| US-6642318-B1 | Sulfur based chain transfer agents; widely compatible; free radical polymerization; producing low polydispersity and predictably specific architecture | E. I. DU PONT DE NEMOURS AND COMPANY | 2003-11-04 | — | — | US | disclosed |
| EP-1054906-A1 | POLYMERIZATION PROCESS WITH LIVING CHARACTERISTICS AND POLYMERS MADE THEREFROM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2000-11-29 | — | — | EP | disclosed |
| WO-1999031144-A1 | POLYMERIZATION PROCESS WITH LIVING CHARACTERISTICS AND POLYMERS MADE THEREFROM | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-06-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12624196-B2 | Rubber composition, vulcanized object obtained from said rubber composition, and vulcanized molded object obtained from said rubber composition | ALG3, VCL, DNMT1 | CA12 1062/4885CA1 315/4885CA2 982/4885 |
| US-20040110964-A1 | Dithiocarbamic esters | DDT, DECR1, PCCA | CA12 2112/4885CA1 3387/4885CA2 2476/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.